Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P 3-G αq coupling

Journal of Cell Science

Volumn 124, Issue 13, 2011, Pages 2220-2230

  Kim, Eun Sook ^a   Kim, Jong Sook ^a   Kim, Sang Geon ^b   Hwang, Sejin ^c   Lee, Chang Ho ^c   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Breast cell invasion; MMP 9; S1P

Indexed keywords

AURORA A KINASE; G PROTEIN COUPLED RECEPTOR; GELATINASE B; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; SPHINGOSINE 1 PHOSPHATE; SYNAPTOPHYSIN;

ARTICLE; BREAST CELL; BREAST EPITHELIUM; CELL INVASION; CONTROLLED STUDY; COUPLING FACTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE; CELL MOVEMENT; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS V-FOS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 79960301614     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.076794     Document Type: Article

References (84)

1. Akasaki, T., Koga, H. and Sumimoto, H. (1999). Phosphoinositide 3-kinase-dependent and -independent activation of the small GTPase Rac2 in human neutrophils. J. Biol. Chem. 274, 18055-18059.
2. Alpaugh, M. L., Tomlinson, J. S., Shao, Z. M. and Barsky, S. H. (1999). A novel human xenograft model of inflammatory breast cancer. Cancer Res. 59, 5079-5084.
3. Ammit, A. J., Hastie, A. T., Edsall, L. C., Hoffman, R. K., Amrani, Y., Krymskaya, V. P., Kane, S. A., Peters, S. P., Penn, R. B., Spiegel, S. et al. (2001). Sphingosine 1- phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 15. 1212-1214.
4. Arikawa, K., Takuwa, N., Yamaguchi, H., Sugimoto, N., Kitayama, J., Nagawa, H., Takehara, K. and Takuwa, Y. (2003). Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J. Biol. Chem. 278, 32841-32851.
5. Azuma, H., Takahara, S., Ichimaru, N., Wang, J. D., Itoh, Y., Otsuki, Y., Morimoto, J., Fukui, R., Hoshiga, M., Ishihara, T. et al. (2002). Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 62, 1410-1419.
6. Barbieri, I., Pensa, S., Pannellini, T., Quaglino, E., Maritano, D., Demaria, M., Voster, A., Turkson, J., Cavallo, F., Watson, C. J. et al. (2010). Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Cancer Res. 70, 2558-2567.
7. Bian, J. and Sun, Y. (1997). Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol. 17, 6330-6338.
8. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P. et al. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457.
9. Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J. M., Bertucci, F., Jacquemier, J. et al. (2010). Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin. Cancer Res. 16, 45-55.
10. Cole, S. W. (2009). Chronic inflammation and breast cancer recurrence. J. Clin. Oncol. 27, 3418-3419.
11. Crowe, D. L. and Brown, T. N. (1999). Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1, 368-372.
12. Devine, K. M., Smicun, Y., Hope, J. M. and Fishman, D. A. (2008). S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. Gynecol. Oncol. 110, 237-245.
13. Fisher, K. E., Pop, A., Koh, W., Anthis, N. J., Saunders, W. B. and Davis, G. E. (2006). Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G- protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol. Cancer 5, 1-23.
14. Gong, Y., Hart, E., Shchurin, A. and Hoover-Plow, J. (2008). Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J. Clin. Invest. 118, 3012-3024.
15. Gräler, M. H. and Goetzl, E. J. (2004). The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18, 551-553.
16. Hait, N. C., Oskeritzian, C. A., Paugh, S. W., Milstien, S. and Spiegel, S. (2006). Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 1758, 2016-2026.
17. Han, S., Ritzenthaler, J. D., Sitaraman, S. V. and Roman, J. (2006). Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J. Biol. Chem. 281, 29614-29624.
18. Heller, R., Chang, Q., Ehrlich, G., Hsieh, S. N., Schoenwaelder, S. M., Kuhlencordt, P. J., Preissner, K. T., Hirsch, E. and Wetzker, R. (2008). Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovasc. Res. 80, 96-105.
19. Hicks, S. N., Jezyk, M. R., Gershburg, S., Seifert, J. P., Harden, T. K. and Sondek, J. (2008). General and versatile autoinhibition of PLC isozymes. Mol. Cell 31, 383-394.
20. Hla, T., Lee, M. J., Ancellin, N., Paik, J. H. and Kluk, M. J. (2001). Lysophospholipids - receptor revelations. Science 294, 875-878.
21. Hojilla, C. V., Wood, G. A. and Khokha, R. (2008). Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer. Breast Cancer Res. 10, 205.
22. Hsieh, H. L., Sun, C. C., Wu, C. B., Wu, C. Y., Tung, W. H., Wang, H. H. and Yang, C. M. (2008). Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. J. Cell. Biochem. 103, 1732-1746.
23. Ishii, I., Friedman, B., Ye, X., Kawamura, S., McGiffert, C., Contos, J. J., Kingsbury, M. A., Zhang, G., Brown, J. H. and Chun, J. (2001). Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J. Biol. Chem. 276, 33697-33704.
24. Ishii, I., Ye, X., Friedman, B., Kawamura, S., Contos, J. J., Kingsbury, M. A., Yang, A. H., Zhang, G., Brown, J. H. and Chun, J. (2002). Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3. J. Biol. Chem. 277, 25152-25159.
25. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M. J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96.
26. Jones, J. L., Glynn, P. and Walker, R. A. (1999). Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1-MMP in primary breast carcinomas. J. Pathol. 189, 161-168.
27. Jongsma, M., van Unen, J., van Loenen, P. B., Michel, M. C., Peters, S. L. and Alewijnse, A. E. (2009). Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). Br. J. Pharmacol. 156, 1305-1311.
28. Katoh, H., Aoki, J., Yamaguchi, Y., Kitano, Y., Ichikawa, A. and Negishi, M. (1998). Constitutively active Galpha12, Galpha13, and Galphaq induce Rho-dependent neurite retraction through different signaling pathways. J. Biol. Chem. 273, 28700-28707.
29. Keely, P. J., Westwick, J. K., Whitchead, I. P., Der, C. J. and Parise, L. Y. (1997). Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390, 632-636.
30. Kim, E. S., Jeong, J. B., Kim, S., Lee, K. M., Ko, E., Noh, D. Y., Hwang, K. T., Ha, J. H., Lee, C. H., Kim, S. G. et al. (2010). The G(12) family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion. Breast Cancer Res. Treat. 124, 49-61.
31. Kim, J. H., Lee, K. W., Lee, M. W., Lee, H. J., Kim, S. H. and Surh, Y. J. (2006). Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-jB as a potential molecular target. FEBS Lett. 580, 385-392.
32. Kim, M. S., Lee, E. J., Kim, H. R. and Moon, A. (2003). p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63, 5454-5461.
33. LaMontagne, K., Littlewood-Evans, A., Schnell, C., O'Reilly, T., Wyder, L., Sanchez, T., Probst, B., Butler, J., Wood, A., Liau, G. et al. (2006). Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res. 66, 221-231.
34. Ma, Z., Qin, H. and Benveniste, E. N. (2001). Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J. Immunol. 167, 5150-5159.
35. Mira, E., Lacalle, R. A., Gómez-Moutón, C., Leonardo, E. and Mañes, S. (2002). Quantitative determination of tumor cell intravasation in a real-time polymerase chain reaction-based assay. Clin. Exp. Metastasis. 19, 313-318.
36. Mizuno, N. and Itoh, H. (2009). Functions and regulatory mechanisms of Gq-signaling pathways. Neurosignals 17, 42-54.
37. Moolenaar, W. H., van Meeteren, L. A. and Giepmans, B. N. (2004). The ins and outs of lysophosphatidic acid signaling. BioEssays 26, 870-881.
38. Moon, A., Kim, M. S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q. and Kim, H. R. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras induced invasive phenotype. Int. J. Cancer. 85, 176-181.
39. Nixon, G. F. (2009). Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br. J. Pharmacol. 158, 982-993.
40. Nyberg, P., Heikkilä, P., Sorsa, T., Luostarinen, J., Heljasvaara, R., Stenman, U. H., Pihlajaniemi, T. and Salo, T. (2003). Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J. Biol. Chem. 278, 22404-22411.
41. Okajima, F., Tomura, H., Sho, K., Nochi, H., Tamoto, K. and Kondo, Y. (1996). Involvement of pertussis toxin-sensitive GTP-binding proteins in sphingosine 1- phosphate-induced activation of phospholipase C-Ca2+ system in HL60 leukemia cells. FEBS Lett. 379, 260-264.
42. Okamoto, H., Takuwa, N., Yokomizo, T., Sugimoto, N., Sakurada, S., Shigematsu, H. and Takuwa, Y. (2000). Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol. Cell. Biol. 20, 9247-9261.
43. Oyesanya, R. A., Greenbaum, S., Dang, D., Lee, Z., Mukherjee, A., Wu, J., Dent, P. and Fang, X. (2010). Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid. Mol. Cancer 9, 8-13.
44. Paik, J. H., Chae, S., Lee, M. J., Thangada, S. and Hla, T. (2001). Sphingosine 1- phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J. Biol. Chem. 276, 11830-11837.
45. Paugh, S. W., Payne, S. G., Barbour, S. E., Milstien, S. and Spiegel, S. (2003). The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554, 189-193.
46. Peng, Y. W., Rhee, S. G., Yu, W. P., Ho, Y. K., Schoen, T., Chader, G. J. and Yau, K. W. (1997). Identification of components of a phosphoinositide signaling pathway in retinal rod outer segments. Proc. Natl. Acad. Sci. USA 94, 1995-2000.
47. Radeke, H. H., von Wenckstern, H., Stoidtner, K., Sauer, B., Hammer, S. and Kleuser, B. (2005). Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J. Immunol. 174, 2778-2786.
48. Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G. and Brown, S. (2009). Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem. 78, 743-768.
49. Roztocil, E., Nicholl, S. M. and Davies, M. G. (2007). Sphingosine-1-phosphate-induced oxygen free radical generation in smooth muscle cell migration requires Galpha12/13 protein-mediated phospholipase C activation. J. Vasc. Surg. 46, 1253-1259.
50. Ryu, Y., Takuwa, N., Sugimoto, N., Sakurada, S., Usui, S., Okamoto, H., Matsui, O. and Takuwa, Y. (2002). Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ. Res. 90, 325-332.
51. Sabbadini, R. A. (2006). Targeting sphingosine-1-phosphate for cancer therapy. Br. J. Cancer 95, 1131-1135.
52. Sato, H., Kita, M. and Seiki, M. (1993). v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268, 23460-23468.
53. 2+ system by sphingosine 1-phosphate in CHO cells transfected with Edg-3, a putative lipid receptor. FEBS Lett. 443, 25-30.
54. Seo, M. and Juhnn, Y. S. (2010). Gq protein mediates UVB-induced cyclooxygenase-2 expression by stimulating HB-EGF secretion from HaCaT human keratinocytes. Biochem. Biophys. Res. Commun. 393, 190-195.
55. Shida, D., Fang, X., Kordula, T., Takabe, K., Lépine, S., Alvarez, S. E., Milstien, S. and Spiegel, S. (2008). Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res. 68, 6569-6577.
56. Shin, I., Kim, S., Song, H., Kim, H. R. and Moon, A. (2005). H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem. 280, 14675-14683.
57. Siehler, S. and Manning, D. R. (2002). Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochim. Biophys. Acta 1582, 94-99.
58. Siehler, S., Wang, Y., Fan, X., Windh, R. T. and Manning, D. R. (2001). Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. J. Biol. Chem. 276, 48733-48739.
59. Smicun, Y., Reierstad, S., Wang, F. Q., Lee, C. and Fishman, D. A. (2006). S1P regulation of ovarian carcinoma invasiveness. Gynecol. Oncol. 103, 952-959.
60. Snyder, J. T., Jezyk, M. R., Gershburg, S., Harden, T. K. and Sondek, J. (2006). Regulation of PLC-beta isoforms by Rac. Methods Enzymol. 6, 272-280.
61. Song, H., Ki, S. H., Kim, S. G. and Moon, A. (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487-10496.
62. Spiegel, S. and Milstien, S. (2003). Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397-407.
63. Stetler-Stevenson, W. G. (1999). Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103, 1237-1241.
64. Sun, Y., Lu, N., Ling, Y., Gao, Y., Chen, Y., Wang, L., Hu, R., Qi, Q., Liu, W., Yang, Y. et al. (2009). Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. Eur. J. Pharmacol. 603, 22-28.
65. Suzuki, N., Nakamura, S., Mano, H. and Kozasa, T. (2003). Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc. Natl. Acad. Sci. USA 100, 733-738.
66. Taha, T. A., Argraves, K. M. and Obeid, L. M. (2004). Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim. Biophys. Acta 1682, 48-55.
67. Takabe, K., Paugh, S. W., Milstien, S. and Spiegel, S. (2008). "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60, 181-195.
68. Takashima, S., Sugimoto, N., Takuwa, N., Okamoto, Y., Yoshioka, K., Takamura, M., Takata, S., Kaneko, S. and Takuwa, Y. (2008). G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. Cardiovasc. Res. 79, 689-697.
69. Takuwa, Y. (2002). Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochim. Biophys. Acta 1582, 112-120.
70. Tauseef, M., Kini, V., Knezevic, N., Brannan, M., Ramchandaran, R., Fyrst, H., Saba, J., Vogel, S. M., Malik, A. B. and Mehta, D. (2008). Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ. Res. 103, 1164-1172.
71. Traurig, H. H. (1967). A radioautographic study of cell proliferation in the mammary gland of the pregnant mouse. Anat. Rec. 159, 239-248.
72. Van Brocklyn, J. R., Lee, M. J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., Thomas, D. M., Coopman, P. J., Thangada, S., Liu, C. H. et al. (1998). Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol. 142, 229-240.
73. Vara Prasad, M. V., Shore, S. K. and Dhanasekaran, N. (1994). Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene 9, 2425-2429.
74. Waeber, C., Blondeau, N. and Salomone, S. (2004). Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. Drug News Perspect. 17, 365-382.
75. Wells, C. D., Liu, M. Y., Jackson, M., Gutowski, S., Sternweis, P. M., Rothstein, J. D., Kozasa, T. and Sternweis, P. C. (2002). Mechanisms for reversible regulation between G13 and Rho exchange factors. J. Biol. Chem. 277, 1174-1181.
76. Windh, R. T., Lee, M. J., Hla, T., An, S., Barr, A. J. and Manning, D. R. (1999). Differential coupling of the sphingosine-1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq and G12 families of heterotrimeric G proteins. J. Biol. Chem. 274, 27351-27358.
77. 2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes. Glia 57, 1775-1789.
78. Wu, W. T., Chen, C. N., Lin, C. I., Chen, J. H. and Lee, H. (2005). Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 146, 3387-3400.
79. Xin, C., Ren, S., Kleuser, B., Shabahang, S., Eberhardt, W., Radeke, H., Schäfer- Korting, M., Pfeilschifter, J. and Huwiler, A. (2004). Sphingosine 1-phosphate cross- activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J. Biol. Chem. 279, 35255-35262.
80. Yamaguchi, H., Kitayama, J., Takuwa, N., Arikawa, K., Inoki, I., Takehara, K., Nagawa, H. and Takuwa, Y. (2003). Sphingosine-1-phosphate receptor subtype- specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem. J. 374, 715-722.
81. Yatomi, Y. (2006). Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Curr. Pharm. Des. 12, 575-587.
82. Yatomi, Y., Igarashi, Y., Yang, L., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Ozaki, Y. and Kume, S. (1997). Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121, 969-973.
83. Young, N., Pearl, D. K. and Van Brocklyn, J. R. (2009). Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol. Cancer Res. 7, 23-32.
84. Zhao, C., Fernandes, M. J., Turgeon, M., Tancrède, S., Di Battista, J., Poubelle, P. E. and Bourgoin, S. G. (2008). Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha. J. Lipid Res. 49, 2323-2337.